Inception Mining Inc (IMII): Announces Additional Drill Program Data

Spotlight Companies  |

Inception Mining Inc. (IMII) is pleased to report the twelfth drill hole in the CMCS drill program (“CMCS-12”), completed at the recently-acquired property adjacent to the Clavo Rico mine site, has encountered gold-bearing oxide content. The property and mine site are located within the town of El Corpus, in the Choluteca department of Honduras.

CMCS-12 was explored to a depth of 50 meters, through which crews drilled to find a heavily oxidized andesitic tuff which hosts a web of iron-, quartz-, and adularia-filled fractures and veins. These fractures and veins are the gold-bearing aspect of the rock. The average grade for the entire hole is 1.55 grams per ton, with the area between meters 6 and 22.5 averaging 2.08 grams per ton. The table below highlights the grade findings resulting from the CMCS-12 exploration. The rock in this section is more oxidized, especially with limonite, and hosts more significant veining than previous drill holes. These fractures and oxides will allow for easier and faster crushing and leaching through our on-site cyanide leach pad.

This hole indicates that Clavo Rico mine has the potential for a sizable extension to its current open pit, located approximately 20 meters due east of CMCS-12.

Stocks To Watch in 5G Wireless Growth Wave

Clavo Rico 2016 Assay Details
Hole From (m)To (m) Length Grade (g/t)
CMCS-12050501.55
Including622.516.52.08
Within which1222.510.52.25
Within which16.519.532.54

About Inception Mining Inc.

We are a producing minerals resource company engaged in the acquisition, exploration, and development of primarily gold related properties. Our primary target properties are those that have been the subject of historical exploration having significant supporting data.

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content